Retinal Vein Occlusion and Diabetic Macular Oedema Trial, Not Yet Recruiting NCT07519707 Sponsor: University of California, San Francisco Condition: Retinal Vein Occlusion and Diabetic Macular Oedema
Back to Retinal Vein Occlusion

Retinal Vein Occlusion and Diabetic Macular Oedema Trial, Not Yet Recruiting

NCT07519707
Not Yet Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with diabetes, with or without an eye condition related to diabetes (called diabetic retinopathy)
  • Your upcoming clinic visit at ZSFG is specifically for managing your diabetes or diabetes-related eye condition
  • You can speak and understand English or Spanish

Who may not be able to join:

  • You are unable to watch or understand videos because of serious vision problems or vision loss

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Sriranjani Padmanabhan, MD, University of California, San Francisco

Phone: 415-353-2020

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 September 2026
Est. completion
1 December 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in Knowledge Concordance Assessed through Validated Questionarres

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov